AI brief of an SEC Form 8-K · U.S. Physical Therapy (USPH)

U.S. Physical Therapy approves 2025 executive incentive plans with Adjusted EBITDA targets

Neutral Impact 3 of 5 leadership Written later

On March 26, 2025, the Compensation Committee of U.S. Physical Therapy's board approved four 2025 incentive plans for senior management, covering long-term equity awards and cash or stock bonuses. Awards depend on 2025 Adjusted EBITDA targets, with grants and bonus decisions set for the first quarter of 2026, so the plans tie executive pay to future earnings performance.

Key points

Maximum long-term restricted stock awards: CEO Christopher Reading 12,500 shares; President Eric Williams 7,500 shares; CFO Carey Hendrickson, COO West Graham Reeve and EVP Rick Binstein 5,000 shares each.
Objective bonus up to 100% of base salary for the CEO and up to 75% for other eligible executives; awards to be determined in the first quarter of 2026.
Awards vest evenly over 16 quarters, beginning May 20, 2026, with final vesting on March 6, 2030.

The filing

CompanyU.S. Physical Therapy (USPH)

Form8-K, current report

Filed with the SECMar 28, 2025, 6:02 AM ET

Accession number0001140361-25-010807

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 28, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.